| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-08 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |